{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-115586","form_type":"8-K","ticker":"ATNM","cik":"0001388320","company_name":"Actinium Pharmaceuticals, Inc.","filed_at":"2025-11-26T23:59:59+00:00","discovered_at":"2026-05-14T18:02:39.281069+00:00","generated_at":"2026-05-16T16:26:44.423787+00:00","sec_items":["5.02","5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Actinium re-elects Shetty and Almenoff as Class III directors at 2025 annual meeting","bullets":["Shetty elected with 5,032,369 for, 1,234,852 withheld; Almenoff with 5,284,503 for, 982,719 withheld.","Ratification of CBIZ as auditor: 13,724,478 for, 1,537,998 against, 232,097 abstain.","Non-binding advisory vote on executive compensation approved: 4,481,875 for, 1,541,460 against.","Advisory vote on frequency of say-on-pay: 1-year interval received most votes (4,645,270).","Total shares present: 15,494,573 of 31,195,891 outstanding; all proposals approved."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-115586","json":"https://secwatch.observer/filing/0001213900-25-115586.json","markdown":"https://secwatch.observer/filing/0001213900-25-115586.md","text":"https://secwatch.observer/filing/0001213900-25-115586.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1388320/000121390025115586/0001213900-25-115586-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1388320/000121390025115586/ea026750301-8k_actinium.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T16:26:44.423787+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}